K. van Dijk

Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units

K. Fischer, S. Gouw, E. Mauser-Bunschoten, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Phenotype of severe hemophilia A and plasma levels of risk factors for thrombosis

K. Fischer, H. M. van den Berg, K. van Dijk, 2007, Journal of thrombosis and haemostasis : JTH.

Use of implantable venous access devices in children with severe hemophilia: benefits and burden.

J. G. van der Bom, K. van Dijk, D. van der Zee, 2004, Haematologica.

Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients

P. Lenting, C. Denis, K. Fischer, 2009, PloS one.

Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature

D. Grobbee, K. Fischer, J. G. van der Bom, 2004, Thrombosis and Haemostasis.

Factor VIII half-life and clinical phenotype of severe hemophilia A.

D. Grobbee, P. D. de Groot, P. Lenting, 2005, Haematologica.

Factor VIII half-life and clinical phenotype of severe hemophilia A.

D. Grobbee, P. D. de Groot, P. Lenting, 2005, Haematologica.